First Time Loading...

Champions Oncology Inc
NASDAQ:CSBR

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
NASDAQ:CSBR
Watchlist
Price: 5.06 USD 0.6%
Updated: Apr 26, 2024

Intrinsic Value

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. [ Read More ]

The intrinsic value of one CSBR stock under the Base Case scenario is 6.67 USD. Compared to the current market price of 5.06 USD, Champions Oncology Inc is Undervalued by 24%.

Key Points:
CSBR Intrinsic Value
Base Case
6.67 USD
Undervaluation 24%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Champions Oncology Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CSBR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Champions Oncology Inc

Provide an overview of the primary business activities
of Champions Oncology Inc.

What unique competitive advantages
does Champions Oncology Inc hold over its rivals?

What risks and challenges
does Champions Oncology Inc face in the near future?

Has there been any significant insider trading activity
in Champions Oncology Inc recently?

Summarize the latest earnings call
of Champions Oncology Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Champions Oncology Inc.

Provide P/S
for Champions Oncology Inc.

Provide P/E
for Champions Oncology Inc.

Provide P/OCF
for Champions Oncology Inc.

Provide P/FCFE
for Champions Oncology Inc.

Provide P/B
for Champions Oncology Inc.

Provide EV/S
for Champions Oncology Inc.

Provide EV/GP
for Champions Oncology Inc.

Provide EV/EBITDA
for Champions Oncology Inc.

Provide EV/EBIT
for Champions Oncology Inc.

Provide EV/OCF
for Champions Oncology Inc.

Provide EV/FCFF
for Champions Oncology Inc.

Provide EV/IC
for Champions Oncology Inc.

Show me price targets
for Champions Oncology Inc made by professional analysts.

What are the Revenue projections
for Champions Oncology Inc?

How accurate were the past Revenue estimates
for Champions Oncology Inc?

What are the Net Income projections
for Champions Oncology Inc?

How accurate were the past Net Income estimates
for Champions Oncology Inc?

What are the EPS projections
for Champions Oncology Inc?

How accurate were the past EPS estimates
for Champions Oncology Inc?

What are the EBIT projections
for Champions Oncology Inc?

How accurate were the past EBIT estimates
for Champions Oncology Inc?

Compare the revenue forecasts
for Champions Oncology Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Champions Oncology Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Champions Oncology Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Champions Oncology Inc compared to its peers.

Compare the P/E ratios
of Champions Oncology Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Champions Oncology Inc with its peers.

Analyze the financial leverage
of Champions Oncology Inc compared to its main competitors.

Show all profitability ratios
for Champions Oncology Inc.

Provide ROE
for Champions Oncology Inc.

Provide ROA
for Champions Oncology Inc.

Provide ROIC
for Champions Oncology Inc.

Provide ROCE
for Champions Oncology Inc.

Provide Gross Margin
for Champions Oncology Inc.

Provide Operating Margin
for Champions Oncology Inc.

Provide Net Margin
for Champions Oncology Inc.

Provide FCF Margin
for Champions Oncology Inc.

Show all solvency ratios
for Champions Oncology Inc.

Provide D/E Ratio
for Champions Oncology Inc.

Provide D/A Ratio
for Champions Oncology Inc.

Provide Interest Coverage Ratio
for Champions Oncology Inc.

Provide Altman Z-Score Ratio
for Champions Oncology Inc.

Provide Quick Ratio
for Champions Oncology Inc.

Provide Current Ratio
for Champions Oncology Inc.

Provide Cash Ratio
for Champions Oncology Inc.

What is the historical Revenue growth
over the last 5 years for Champions Oncology Inc?

What is the historical Net Income growth
over the last 5 years for Champions Oncology Inc?

What is the current Free Cash Flow
of Champions Oncology Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Champions Oncology Inc.

Financials

Balance Sheet Decomposition
Champions Oncology Inc

Current Assets 13.2m
Cash & Short-Term Investments 4.5m
Receivables 7.9m
Other Current Assets 835k
Non-Current Assets 13.6m
PP&E 13.1m
Intangibles 335k
Other Non-Current Assets 185k
Current Liabilities 22m
Accounts Payable 4.8m
Accrued Liabilities 3.7m
Other Current Liabilities 13.5m
Non-Current Liabilities 6.9m
Other Non-Current Liabilities 6.9m
Efficiency

Earnings Waterfall
Champions Oncology Inc

Revenue
49.2m USD
Cost of Revenue
-29.5m USD
Gross Profit
19.7m USD
Operating Expenses
-29.3m USD
Operating Income
-9.6m USD
Other Expenses
-129k USD
Net Income
-9.7m USD

Free Cash Flow Analysis
Champions Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CSBR Profitability Score
Profitability Due Diligence

Champions Oncology Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
26/100
Profitability
Score

Champions Oncology Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

CSBR Solvency Score
Solvency Due Diligence

Champions Oncology Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
44/100
Solvency
Score

Champions Oncology Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CSBR Price Targets Summary
Champions Oncology Inc

Wall Street analysts forecast CSBR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
20% Upside
Average
Price Target
6.12 USD
21% Upside
Highest
Price Target
6.3 USD
25% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CSBR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CSBR Price
Champions Oncology Inc

1M 1M
+1%
6M 6M
-17%
1Y 1Y
+1%
3Y 3Y
-51%
5Y 5Y
-43%
10Y 10Y
-59%
Annual Price Range
5.06
52w Low
4.27
52w High
7.32
Price Metrics
Average Annual Return -11.31%
Standard Deviation of Annual Returns 33.58%
Max Drawdown -73%
Shares Statistics
Market Capitalization 68.8m USD
Shares Outstanding 13 593 800
Percentage of Shares Shorted 0.84%

CSBR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Champions Oncology Inc Logo
Champions Oncology Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

68.8m USD

Dividend Yield

0%

Description

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Baltimore, Maryland and currently employs 194 full-time employees. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.

Contact

MARYLAND
Baltimore
855 N Wolfe St Ste 619
+14103690365.0
https://championsoncology.com

IPO

1988-11-30

Employees

194

Officers

CEO & Director
Dr. Ronnie Morris M.D.
Chief Financial Officer
Mr. David Barry Miller M.B.A.
President
Mr. Brady Davis
Chief Operating Officer
Dr. Maria Mancini Ph.D.
Vice President of Technology
Mr. Arthur Hanson
VP of Global Marketing
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS
Show More
Executive Vice President of Global Laboratory Operations
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG
Chief Commercial Officer
Dr. Michael Ritchie M.B.A., Ph.D.
Executive Vice President of Global Scientific Operations
Dr. Karin Abarca Heidemann Ph.D.
Executive Vice President of Commercial, Research Services & Partnering
Dr. Marianna Zipeto Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one CSBR stock?

The intrinsic value of one CSBR stock under the Base Case scenario is 6.67 USD.

Is CSBR stock undervalued or overvalued?

Compared to the current market price of 5.06 USD, Champions Oncology Inc is Undervalued by 24%.